Bell’s palsy is the most common cause of sudden facial paralysis and can be alarming for patients because its symptoms often resemble those of a stroke. Although the condition typically develops abruptly, most individuals recover fully with appropriate treatment and supportive care.
Understanding the signs of Bell’s palsy, how it differs from other neurological conditions, and the importance of early treatment can help improve outcomes and reduce complications.
Bell’s palsy is an acute, isolated paralysis of the facial nerve (cranial nerve VII) that occurs without evidence of brain dysfunction or other systemic neurological disease.
It is classified as a peripheral (lower motor neuron) facial nerve palsy, meaning the problem occurs in the facial nerve itself rather than within the brain.
The condition almost always affects one side of the face and develops suddenly, often reaching maximum weakness within hours to days.
The exact cause of Bell’s palsy remains unknown. However, the condition is believed to result from inflammation and swelling of the facial nerve as it travels through the narrow bony canal within the temporal bone. The swollen nerve becomes compressed, impairing its normal function.
Several viral infections have been associated with Bell’s palsy, including:
Certain bacterial infections, particularly Lyme disease, may also produce facial nerve paralysis and should be considered in appropriate clinical settings.
Bell’s palsy can occur at any age but is more commonly seen in:
Although anyone can develop Bell’s palsy, these groups have a higher incidence than the general population.
The hallmark feature is sudden weakness or paralysis affecting one side of the face.
Patients may notice:
Because the facial muscles become weak, facial expressions appear noticeably asymmetrical.
Some individuals also experience:
These symptoms occur because the facial nerve controls much more than facial movement alone.
One helpful feature of Bell’s palsy is that several neurological functions remain unaffected.
Patients generally have:
The absence of these additional neurological abnormalities helps distinguish Bell’s palsy from more serious conditions such as stroke.
The outlook for Bell’s palsy is generally excellent.
Most patients begin to notice improvement within a few weeks, and complete recovery occurs within approximately six months.
Although the majority recover fully, a small percentage may experience persistent weakness or mild facial asymmetry.
Because Bell’s palsy causes sudden facial weakness, it is often confused with a stroke.
However, there are several important differences.
Bell’s palsy affects the entire half of the face, including the forehead.
Patients are unable to:
Facial weakness caused by a central nervous system lesion, such as a stroke, typically spares the forehead because the forehead receives nerve signals from both sides of the brain.
Patients with stroke often have additional neurological deficits, including:
These associated findings help differentiate stroke from isolated Bell’s palsy and require immediate emergency evaluation.
Several disorders may present with facial weakness and should be considered during evaluation.
These include:
A careful history and neurological examination help narrow the diagnosis.
Bell’s palsy is primarily a clinical diagnosis, based on the patient’s history and physical examination.
Most patients do not require routine imaging.
CT scans or MRI studies are generally reserved for individuals with:
Additional testing may include:
If symptoms fail to improve after 6 to 8 weeks, further evaluation is recommended to rule out alternative diagnoses.
The most effective treatment for Bell’s palsy is oral corticosteroid therapy, such as prednisone.
The recommended regimen is prednisone 50–60 mg daily for 5 days followed by a 5-day taper. A cumulative dose of ≥450 mg is associated with better outcomes.
The American Academy of Neurology (AAN) strongly recommends starting corticosteroids within 72 hours of symptom onset, as early treatment significantly improves the likelihood of complete facial nerve recovery.
There is little evidence that beginning steroid therapy after this window provides substantial benefit.
Combination therapy with corticosteroids and antivirals consistently reduces rates of synkinesis, though the effect on complete recovery is less clear. The AAN assigns antivirals (in addition to steroids) a Level C recommendation, noting that any benefit is modest at best (risk difference <7%). Commonly used regimens include:
Antivirals should not be used as monotherapy, as there is strong evidence they are ineffective alone.does not support routine antiviral therapy as the primary treatment for Bell’s palsy.
One of the most important aspects of management is protecting the affected eye.
Because patients may be unable to close the eyelid completely, the cornea is at risk for drying, irritation, and injury.
Recommended eye care includes:
Patients with significant eye involvement should be referred to an eye care specialist to prevent corneal damage.
For patients with incomplete recovery, facial exercises and physical therapy may be considered to help improve muscle function and reduce long-term weakness.
